Director Don Hankey resigns from Bone Biologics board effective Oct 1, 2024

Bone Biologics Corp

Don Hankey resigned as director of Bone Biologics effective October 1, 2024.
Resignation was not due to any disagreement with the Company's operations, policies, or practices.
Company expressed appreciation for Mr. Hankey's years of service as a director.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Don Hankey

director

BBLG · Bone Biologics Corp

Effective: 2024-10-01
Filed: October 4, 2024, 7:59 PM ET

On October 1, 2024, Don Hankey informed Bone Biologics Corporation (the “Company”) of his resignation as a director of the Company effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Don Hankey resigned as director at Bone Biologics Corp.

Action: resigned
Role: director

Exact text from the filing

On October 1, 2024, Don Hankey informed Bone Biologics Corporation (the “Company”) of his resignation as a director of the Company effective immediately.

View on SEC.gov

Bone Biologics Corp filing history →

Source: SEC EDGAR

accession 0001493152-24-039554

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.